Company profile for Encoded Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our goal at Encoded is the development of viral gene therapies that provide life-changing benefits to individuals with genetic disorders. With recent advancements in sequencing technologies and gene-based medicines, symptomatic treatment and chronic disease management are no longer enough. Instead, we believe in creating treatment options that provide lasting benefit to dramatically improve lives. Our diverse and impactful gen...
Our goal at Encoded is the development of viral gene therapies that provide life-changing benefits to individuals with genetic disorders. With recent advancements in sequencing technologies and gene-based medicines, symptomatic treatment and chronic disease management are no longer enough. Instead, we believe in creating treatment options that provide lasting benefit to dramatically improve lives. Our diverse and impactful gene therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways, including: neurocircuitry, liver and metabolic disorders, neurodegeneration, and cardiovascular disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
341 Oyster Point Blvd. South San Francisco, CA 94080
Telephone
Telephone
650.491.0272
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251216682441/en/Encoded-Therapeutics-Strengthens-Clinical-Leadership-Team-with-Appointment-of-Professor-Joseph-Sullivan-M.D.-as-Vice-President-of-Clinical-Development

BUSINESSWIRE
16 Dec 2025

https://www.fiercebiotech.com/biotech/encoded-deciphers-path-pivotal-trial-phase-12-dravet-gene-therapy-data

FIERCE BIOTECH
05 Dec 2025

https://www.businesswire.com/news/home/20251201429589/en/Encoded-Therapeutics-to-Present-Interim-Phase-12-Clinical-Data-on-ETX101-the-First-One-time-Gene-Therapy-in-Development-for-Dravet-Syndrome-at-the-2025-American-Epilepsy-Society-Annual-Meeting

BUSINESSWIRE
01 Dec 2025

https://www.pharmiweb.com/press-release/2025-10-09/new-preclinical-data-from-encoded-therapeutics-demonstrate-therapeutic-potential-of-its-one-time-no

PHARMIWEB
09 Oct 2025

https://www.pharmiweb.com/press-release/2025-09-02/encoded-therapeutics-announces-regenerative-medicine-advanced-therapy-rmat-designation-granted-by

PHARMAWEB
02 Sep 2025

https://www.businesswire.com/news/home/20250513670977/en/Encoded-Therapeutics-Presents-Promising-New-Data-for-CNS-Gene-Therapy-Programs-at-the-ASGCT-28th-Annual-Meeting

BUSINESSWIRE
13 May 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty